Company page

Volitionrx Limited

Volitionrx Limited, trading under the ticker VNRX, is a public company based in the United States with a market capitalization of approximately $11.9 million. The company focuses on developing innovative diagnostic tests for cancer and other diseases. Volitionrx aims to improve patient outcomes through its advanced technology and research in the field of diagnostics.